Global Cancer Drugs Market Size & Share Will Grow USD

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
90
Global Cancer Drugs Market Size & Share Will Grow USD 161.30 Billion by 2021: Zion Market Research

Sarasota, FL, July 03, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) for Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021” . According to the report, global  cancer drugs market  was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021. 

Cancer is defined as a disease which occurs as a result of changes in a group of normal cells within the body which leads to uncontrolled growth resulting in the formation of lump called a tumor; (except for cancer of the blood). If left untreated, tumors can grow and spread into the surrounding normal tissue, or to other parts of the body via lymphatic systems and the bloodstream, and can in turn severely impact the functioning of the digestive, nervous and circulatory systems.

Browse through 27 Market Tables and 25 Figures spread through 110 Pages and in-depth TOC on “Global Cancer Drugs Market: Type, Size, Share, Trends, Review, Analysis, Segment and Forecast 2015-2021”.

Request Free Sample copy of Global Cancer Drugs Market Report @ https://www.zionmarketresearch.com/sample/can...ugs-market

Global cancer drugs market is primarily driven by growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. across the globe. Other major driving factors are increasing research and development on biological and targeted drug therapies for the treatment of cancer coupled along with the expiration of patents. However, the high price of drug development and stringent regulatory policies coupled along with the possibility of failure are the major restraints that may limit the growth of the market. Nonetheless increasing focus on personalized medicine coupled along with huge investment in anti-cancer drugs research across the globe is likely to disclose the new avenues for cancer drugs market in the near future.

The cancer drugs market is segmented on the basis of the different therapeutic segment including immunotherapy, targeted therapy, chemotherapy, hormone therapy and others. Immunotherapy segment is expected to grow at fastest rate in the global market over the forecast period.

Browse the full " Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) for Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2015 - 2021 " report at  https://www.zionmarketresearch.com/report/can...ugs-market

Breast cancer, blood cancer, gastrointestinal cancer, prostate cancer, skin cancer, lung cancer and others are the key cancer types of the global cancer drugs market. The blood cancer segment dominated the market in terms of revenue. 

North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global cancer drugs market. North America is anticipated to remain the leading region over the forecast period in 2015. Demand for cancer drugs was highest in North America especially in the U.S. Hence, Asia Pacific is expected to be the moderate growing region in cancer drugs market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show moderate growth for this market in the years to come.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/ca...ugs-market

Some of the key players in cancer drugs market include Bayer, GlaxoSmithKline, Novartis, Sanofi and Pfizer, Amgen, Merck, Bristol-Myers Squibb, Celgene Corporation, Ariad Pharmaceuticals, Eli Lilly, Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, Johnson and Johnson and Teva Pharmaceuticals among others.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/490

This report segments the global cancer drugs market as follows: Global Cancer Drugs Market: Therapy Segment Analysis

  • Immunotherapy
  • Targeted Therapy
  • Chemotherapy
  • Hormone Therapy
  • Others

Global Cancer Drugs Market: Application Segment Analysis.

  • Breast Cancer
  • Blood Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Skin Cancer
  • Lung Cancer
  • Others

Global Cancer Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stellus Capital Delivers Solid Q3 Amid Turbulent Times

Updated Category News Views 7

Unpacking Stellus Capital's Latest Quarter Boy, Stellus Capital sure knows how to keep us on our toes. In a landscape where many are still reeling from the latest market tremors, they post some solid Q3 numbers for September 30, 2026. Not without its hiccups, but hey, who isn’t stumbling a bit right now? Financial Snapshot: Stability Amidst Uncertainty Stellus reported...

Continue Reading
New Leadership at Reactive Tech: Claudio Facchin Steps In

Updated Category News Views 154

Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...

Continue Reading
Outer Spaces Unveils OS1 at Major Energy Expo

Updated Category News Views 98

Introduction to the Future of Solar Living Just when you thought you'd seen it all, along comes Outer Spaces with their OS1—a solar pavilion and battery deck that looks at residential energy with fresh eyes. Debuting at the RE+ 2026 in Las Vegas, this isn't just another gizmo. This is about bringing solar power to your backyard without making your roof look like it...

Continue Reading
Chicago Marathon Spurs $1M for Suicide Prevention

Updated Category News Views 49

Marathon Fundraising Hits New Heights Surpassing a million bucks in one marathon run—a result you don't see every day. Yet, that's what happened when the AFSP's Race for Hope team took to the Chicago streets. October 11, 2026, tagged them as fundraising champs, setting an Illinois record for suicide prevention efforts. A Journey of Passion and Purpose What started 16...

Continue Reading
Yiren Digital Faces Tough Road Amid Legal Headaches

Updated Category News Views 47

Trouble Brewing for Yiren Digital Cracks in the wall, or just another storm for YRD investors? Folks investing in Yiren Digital Ltd. got a shock as the stock took a plunge by a staggering 44.05%. This ain't your typical day on Wall Street. The collapse followed the messy disclosure of alleged securities fraud, shaking up the trust these guys had from April to October...

Continue Reading
PNU and Cellenkos Team Up for Biotech Advancements

Updated Category News Views 121

Paving New Paths in Biotech Collaboration When a university and a biotech company shake hands to bolster their capabilities in the ever-evolving field of clinical trials and cell and gene therapies, investors and industry buffs alike should perk up. The College of Medicine at Princess Nourah bint Abdulrahman University (PNU) has just inked a Memorandum of Understanding...

Continue Reading
Craveworthy Brands Aims to Triple Wing It On!'s Size

Updated Category News Views 19

New Frontiers: Merging Pizza Past with Wing Future Buying pizza joints to roll out wings? Sounds like Craveworthy's pulling a fast one. Well, not quite. They're onto something here—taking over Papa Gino's to boost their Wing It On! brand. It’s a blend of big pies and buffalo wings, all rooted in New England’s savory history. What's in a Deal? Here’s the scoop:...

Continue Reading
Expo 2027 Belgrade Volunteer Rush: A Global Draw

Updated Category News Views 191

Massive Volunteer Interest for Expo 2027 Belgrade Maybe I’m getting soft, but there’s something about the human spirit rallying around big events that gets me, even after seeing my share of market rollercoasters. Expo 2027 in Belgrade is attracting an army of volunteers—over 19,000 folks hankering to lend a hand from 154 different countries. Yeah, you read that...

Continue Reading
U.S. Money Reserve Earns Top Workplace Nod Again

Updated Category News Views 14

Celebrating Another Year of Workplace Excellence Ah, the old adage: a company is only as good as its people. Well, U.S. Money Reserve seems to have taken that to heart, as they snag their second consecutive "Top Workplace" title in Austin. Now, it ain't every day you see a company score high marks on employee satisfaction, especially for two years in a row. But here they...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 109

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Diana Shipping Inc. Reports Significant Growth Amid Challenges

Updated Category News Views 194

Diana Shipping Inc. Financial Results Overview ATHENS, Greece — Diana Shipping Inc. (NYSE: DSX), known for its expertise in owning and chartering dry bulk vessels, recently shared its impressive net income results for the third quarter of 2025. The company posted a net income of $7.2 million this quarter, which translates to $0.05 per share. This marks a notable...

Continue Reading
SentinelOne Faces Analyst Downgrade Ahead of Q4 Results

Updated Category News Views 227

SentinelOne’s Analysts Adjust Predictions Shares of SentinelOne Inc (NYSE: S) have shown a decline as investors anticipate the company's upcoming fourth-quarter results. These results are expected to provide insight into the company's growth prospects and profitability. Expectations for Q4 Results JPMorgan analysts forecast that SentinelOne will report slightly better...

Continue Reading
Autogun Heroes: Supercharged Launches for Thrilling Gameplay

Updated Category News Views 242

Autogun Heroes: Supercharged Now on Steam Revive your passion for retro gaming with the heart-pounding action of Autogun Heroes: Supercharged. Nitro Games has just rolled out this dynamic shoot 'em up adventure, inviting gamers from all around to experience an engaging tribute to the classics. Experience the Excitement This game signifies an exhilarating new phase in the...

Continue Reading
Stantec's Record Growth in Q3 2024: A Path Forward

Updated Category News Views 235

Stantec Achieves Record Growth in Q3 2024 Highlights of the Third Quarter Net revenue reached $1.5 billion, marking a 15.8% increase year-over-year. Adjusted EBITDA rose 13.8% to $274.6 million with an EBITDA margin of 18.0%. Adjusted diluted EPS of $1.30, reflecting a 14.0% growth compared to the previous year. The company's backlog reached an all-time high of $7.3...

Continue Reading
Infosys and Lufthansa Group Team Up for Digital Innovation

Updated Category News Views 370

Innovative Collaboration in Aviation Technology In a transformative step for the aviation industry, Infosys, a global leader in next-generation digital services, has partnered with the Lufthansa Group and Lufthansa Systems. This collaboration aims to accelerate digital transformation within the aviation sector by enhancing operational efficiencies and passenger...

Continue Reading